Company profile CDTX
After 92 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 0 days it will total up to 0.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 0 |
| 2019 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 35 inf% YoY inf% QoQ | 74 inf% YoY 111.4% QoQ | 112 inf% YoY 51.4% QoQ |
| 2021 | 118 inf% YoY 5.4% QoQ | 48 37.1% YoY -59.3% QoQ | 229 209.5% YoY 377.1% QoQ | 126 12.5% YoY -45.0% QoQ |
| 2022 | 176 49.2% YoY 39.7% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
The average 5 years interest of Cidara Therapeutics was 3.53 per week. The last year interest of Cidara Therapeutics compared to the last 5 years has changed by -100.0%. This is something to be checked. This didn't exist 5 years ago.
There is not enough data for rezafungin acetate to provide analysis
There is not enough data for rezafungin acetate to provide correlation calculation
There is not enough data for rezafungin acetate to provide analysis
There is not enough data for echinocandin antifungals to provide analysis
There is not enough data for echinocandin antifungals to provide correlation calculation
There is not enough data for echinocandin antifungals to provide analysis
After 39 days of this quarter the interest is at 34.0. Based on that we can calculate that during remaining 52 days it will total up to 79.0. invasive fungal infections expected interest is significantly higher compared to previous quarter (+64.6%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 52 | 272 423.1% QoQ | 188 -30.9% QoQ | 76 -59.6% QoQ |
| 2020 | 122 134.6% YoY 60.5% QoQ | 94 -65.4% YoY -23.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 192 152.6% YoY inf% QoQ |
| 2021 | 217 77.9% YoY 13.0% QoQ | 102 8.5% YoY -53.0% QoQ | 235 inf% YoY 130.4% QoQ | 78 -59.4% YoY -66.8% QoQ |
| 2022 | 143 -34.1% YoY 83.3% QoQ | 88 -13.7% YoY -38.5% QoQ | 112 -52.3% YoY 27.3% QoQ | 173 121.8% YoY 54.5% QoQ |
| 2023 | 97 -32.2% YoY -43.9% QoQ | 248 181.8% YoY 155.7% QoQ | 253 125.9% YoY 2.0% QoQ | 48 -72.3% YoY -81.0% QoQ |
| 2024 | 34 -64.9% YoY -29.2% QoQ | - | - | - |
The average 5 years interest of invasive fungal infections was 10.82 per week. The last year interest of invasive fungal infections compared to the last 5 years has changed by 8.04%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 0.17%.
There is not enough data for Cloudbreak platform to provide analysis
There is not enough data for Cloudbreak platform to provide correlation calculation
There is not enough data for Cloudbreak platform to provide analysis
After 39 days of this quarter the interest is at 113.0. Based on that we can calculate that during remaining 52 days it will total up to 264.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 299 | 233 -22.1% QoQ | 252 8.2% QoQ | 293 16.3% QoQ |
| 2020 | 613 105.0% YoY 109.2% QoQ | 270 15.9% YoY -56.0% QoQ | 435 72.6% YoY 61.1% QoQ | 210 -28.3% YoY -51.7% QoQ |
| 2021 | 193 -68.5% YoY -8.1% QoQ | 215 -20.4% YoY 11.4% QoQ | 200 -54.0% YoY -7.0% QoQ | 218 3.8% YoY 9.0% QoQ |
| 2022 | 364 88.6% YoY 67.0% QoQ | 330 53.5% YoY -9.3% QoQ | 228 14.0% YoY -30.9% QoQ | 426 95.4% YoY 86.8% QoQ |
| 2023 | 260 -28.6% YoY -39.0% QoQ | 295 -10.6% YoY 13.5% QoQ | 191 -16.2% YoY -35.3% QoQ | 293 -31.2% YoY 53.4% QoQ |
| 2024 | 113 -56.5% YoY -61.4% QoQ | - | - | - |
The average 5 years interest of influenza prevention was 22.72 per week. The last year interest of influenza prevention compared to the last 5 years has changed by -11.05%. The interest for influenza prevention is seasonal. The last year interest is quite lower compared to 5 years ago. It has decreased by -19.48%.
After 39 days of this quarter the interest is at 133.0. Based on that we can calculate that during remaining 52 days it will total up to 310.0. RSV treatment expected interest is significantly higher compared to same quarter last year (+84.5%) but lower than previous quarter (-43.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 44 | 18 -59.1% QoQ | 20 11.1% QoQ | 131 555.0% QoQ |
| 2020 | 98 122.7% YoY -25.2% QoQ | 9 -50.0% YoY -90.8% QoQ | 14 -30.0% YoY 55.6% QoQ | 15 -88.5% YoY 7.1% QoQ |
| 2021 | 13 -86.7% YoY -13.3% QoQ | 59 555.6% YoY 353.8% QoQ | 230 1542.9% YoY 289.8% QoQ | 170 1033.3% YoY -26.1% QoQ |
| 2022 | 57 338.5% YoY -66.5% QoQ | 54 -8.5% YoY -5.3% QoQ | 98 -57.4% YoY 81.5% QoQ | 800 370.6% YoY 716.3% QoQ |
| 2023 | 168 194.7% YoY -79.0% QoQ | 63 16.7% YoY -62.5% QoQ | 92 -6.1% YoY 46.0% QoQ | 544 -32.0% YoY 491.3% QoQ |
| 2024 | 133 -20.8% YoY -75.6% QoQ | - | - | - |
The average 5 years interest of RSV treatment was 10.84 per week. The last year interest of RSV treatment compared to the last 5 years has changed by 59.5%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 234.43%.
After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 123 |
| 2019 | 297 141.5% QoQ | 193 -35.0% QoQ | 161 -16.6% QoQ | 165 34.1% YoY 2.5% QoQ |
| 2020 | 235 -20.9% YoY 42.4% QoQ | 132 -31.6% YoY -43.8% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2021 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2022 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
The average 5 years interest of HIV cure was 5.0 per week. The last year interest of HIV cure compared to the last 5 years has changed by -100.0%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -100.0%.
After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0. SARS-CoV-2 strains expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 0 |
| 2019 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 |
| 2022 | 80 inf% YoY inf% QoQ | 104 inf% YoY 30.0% QoQ | 247 inf% YoY 137.5% QoQ | 243 inf% YoY -1.6% QoQ |
| 2023 | 230 187.5% YoY -5.3% QoQ | 282 171.2% YoY 22.6% QoQ | 153 -38.1% YoY -45.7% QoQ | 0 -100.0% YoY -100.0% QoQ |
The average 5 years interest of SARS-CoV-2 strains was 5.13 per week. The last year interest of SARS-CoV-2 strains compared to the last 5 years has changed by 240.35%. This is something to be checked. This didn't exist 5 years ago.
After 39 days of this quarter the interest is at 31.0. Based on that we can calculate that during remaining 52 days it will total up to 72.0. Cidara Therapeutics -stock -company expected interest is significantly lower compared to same quarter last year (-73.1%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 148 | 132 -10.8% QoQ | 97 -26.5% QoQ | 88 -9.3% QoQ |
| 2020 | 95 -35.8% YoY 8.0% QoQ | 206 56.1% YoY 116.8% QoQ | 147 51.5% YoY -28.6% QoQ | 44 -50.0% YoY -70.1% QoQ |
| 2021 | 152 60.0% YoY 245.5% QoQ | 84 -59.2% YoY -44.7% QoQ | 68 -53.7% YoY -19.0% QoQ | 134 204.5% YoY 97.1% QoQ |
| 2022 | 103 -32.2% YoY -23.1% QoQ | 111 32.1% YoY 7.8% QoQ | 217 219.1% YoY 95.5% QoQ | 128 -4.5% YoY -41.0% QoQ |
| 2023 | 268 160.2% YoY 109.4% QoQ | 135 21.6% YoY -49.6% QoQ | 59 -72.8% YoY -56.3% QoQ | 69 -46.1% YoY 16.9% QoQ |
| 2024 | 31 -88.4% YoY -55.1% QoQ | - | - | - |
The average 5 years interest of Cidara Therapeutics -stock -company was 9.64 per week. The last year interest of Cidara Therapeutics -stock -company compared to the last 5 years has changed by -3.22%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -7.9%.